Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
ILA-H525f | Human | Human IL-17 RA / CD217 Protein, Fc Tag (MALS verified) |
|
|
|
ILR-H82E5 | Human | Biotinylated Human IL-17 RA / CD217 Protein, His,Avitag™ |
|
|
|
ILA-H82F1 | Human | Biotinylated Human IL-17 RA / CD217 Protein, Fc,Avitag™ |
|
|
|
ILA-H5222 | Human | Human IL-17 RA / CD217 Protein, His Tag |
|
|
Loaded Biotinylated Human IL-17 RA, Fc,Avitag (Cat. No. ILA-H82F1) on SA Biosensor, can bind Human IL17A, Tag Free with an affinity constant of 1.29 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Brodalumab | IL-17R mAb; MEDI-6365; KHK-4827; AMG-827 | Approved | Amgen Inc | Siliq, Lumicef, Kyntheum, 立美芙 | Japan | Psoriasis; Arthritis, Psoriatic | Kyowa Kirin Co Ltd | 2016-07-04 | Non-radiographic axial spondyloarthritis; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Scleroderma, Systemic; Psoriasis; Asthma; Arthritis, Psoriatic; Hidradenitis Suppurativa; Crohn Disease; Plaque psoriasis | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
XCUR-17 | XCUR-17 | Phase 1 Clinical | Exicure Inc | Psoriasis | Details |
This web search service is supported by Google Inc.